Background

Apicomplexan haemoparasites are protozoans that infect a wide variety of domestic and wild animals, as well as humans [1, 2]. The complex interactions between domestic animals, wild reservoirs and arthropod vectors favour tick-borne pathogen transmission and increase their geographical distribution [3]. During the last decades, several studies have focused on the detection and characterization of haemoprotozoans in domestic dog populations worldwide [4,5,6,7]. However, in domestic cats, data regarding the presence of haemoprotozoans are scarce.

Genus Babesia includes more than 100 species, with intraerythrocytic localization in the vertebrate host, causing mild to severe haemolytic diseases [2, 8]. Several ixodid ticks are thought to be involved in their transmission, although vector competence has not been confirmed in all cases [9]. Feline babesiosis is a relatively newly recognized clinical entity, with most available studies originating from South Africa [10]. Non-specific clinical signs such as anaemia, lethargy, and anorexia are described, whereas icterus and fever are inconsistently found [11]. While several Babesia spp. have been documented in domestic cats, the species most commonly associated with clinical cases is Babesia felis [10]. In Europe, Babesia microti [12, 13] and dog-related species such as Babesia canis [14, 15], Babesia vogeli [15, 16], and Babesia vulpes (formerly known as Theileria annae) [14, 17] have been detected in domestic cats. Nevertheless, the European cases were rarely associated with clinical manifestations. Recently, Babesia pisicii was described in European wild cats, Felis silvestris in Romania [18], but its presence in domestic cats has not been documented yet.

Hepatozoon spp. are haemogregarines with a life-cycle shared between a wide range of vertebrates as intermediate hosts and various haematophagous arthropods as definitive hosts [19]. The main transmission pathway is represented by the ingestion of the arthropod definitive host containing mature sporozoites by the intermediate host [20]. In domestic cats, Hepatozoon spp. were reported for the first time in India [21]. Since then, Hepatozoon infections have been found in domestic cats and various wild felids worldwide [22]. In Europe, Hepatozoon felis is recognized as the main agent infecting domestic and wild felines [15, 16, 23,24,25,26,27,28,29,30,31,32,33,34,35,36]. Hepatozoon canis has also been reported in domestic cats in Europe [28, 29, 37,38,39]. Recently, a novel species, Hepatozoon silvestris, was described in European wild cats from Bosnia and Herzegovina [30] and was further reported in domestic [29, 35, 40] and wild felids [31] in Europe. Feline hepatozoonosis is mostly subclinical, with no significant inflammatory response in association with the presence of meronts in muscle tissue [26, 31].

Feline cytauxzoonosis, first described in the 1970s [41], is a tick-borne disease affecting both domestic and wild felids [42]. Five Cytauxzoon species have been described so far in felids Cytauxzoon felis, Cytauxzoon manul, Cytauxzoon europaeus, Cytauxzoon banethi, and Cytauxzoon otrantorum. Cytauxzoon felis is considered endemic to North America, causing a highly fatal disease in domestic cats, in both natural and experimental infections [43]. Bobcats (Lynx rufus) are the natural reservoirs [3]. In 2005, C. manul was described from Pallas’ cats (Otocolobus manul) imported from Mongolia to the USA [44, 45]. In Europe, unnamed isolates of Cytauxzoon have been documented in the past decade in domestic cats [28, 35, 39, 46,47,48,49,50,51,52,53], Iberian lynx (Lynx pardinus) [54,55,56,57,58,59], Eurasian Lynx (Lynx lynx) [60], and European wild cats [31, 60,61,62]. In a breeding centre in Russia, Cytauxzoon spp. were identified in a serval, a bobcat, seven Amur wild cats, and two domestic cats [63]. Recently, three Cytauxzoon species were described in European wild cats: C. europaeus, which was identified in several central, eastern, and southern European countries [64,65,66,67], and C. banethi and C. otrantorum, which to date had been identified only in Romania [64]. Additionally, C. europaeus was identified in domestic and stray cats in Switzerland [65]. However, no data are available on the clinical significance of these species for domestic cats.

No previous studies are available on apicomplexan haemoparasites in domestic cats in Romania, and data from Eastern Europe is generally very limited. Therefore, the aim of this study was to investigate the occurrence of Babesia spp., Cytauxzoon spp., and Hepatozoon spp. in domestic cats in Romania using highly specific polymerase chain reaction (PCR) protocols and to identify the potential risk factors associated with these infections.

Methods

Sample and data collection

Blood samples from 371 domestic cats were collected between October 2017 and May 2019. The animals included in the study were client-owned (referred to urban private veterinary clinics or from rural areas), stray (from animal shelters), or feral (living in cat colonies). Whole blood samples were collected into sterile tubes containing anticoagulant (ethylenediaminetetraacetic acid [EDTA] or citrate) after obtaining informed consent for patient enrolment from the owners. The samples were stored at −20 °C until further analysis.

Outdoor access and age (cats older than 4 months) were considered as inclusion criteria. When available, epidemiological data (sex, age, breed, lifestyle, habitat, and ecoregion) were noted for each animal.

Molecular and phylogenetic analyses

Genomic DNA was isolated using the Isolate II Genomic DNA Kit (Meridian Bioscience, London, UK) from 200 µl of whole blood, following the manufacturer’s instructions. Each DNA sample was stored at −20 °C until further use.

A highly sensitive nested PCR protocol targeting a 561–613-base pair (bp) fragment of 18S ribosomal DNA (18S rDNA) of piroplasmids (Cytauxzoon spp., Babesia spp., Theileria spp., and Hepatozoon spp.) was used for initial screening. Due to the high number of weak bands and the low quality of the sequences obtained, all positive or dubious samples were subsequently screened by specific nested PCR assays targeting the 18S rDNA of Babesia spp., Cytauxzoon spp., and Hepatozoon spp. Moreover, nested PCR assays targeting the cytochrome b (Cytb) and cytochrome c oxidase subunit I (COI) genes of Babesia spp. were used for screening of all Babesia spp.-positive samples. Primers and PCR conditions are detailed in Table 1.

Table 1 Primer pairs and PCR conditions used for PCR amplification

First-round reactions were carried out in a total volume of 15 μl containing 7.5 μl of 2× PCRBIO Taq Mix Red (PCR Biosystems, London, UK), 400 nM of each primer, and 1 μl of template DNA, except for the amplification of the partial 18S rDNA of piroplasmids that was performed using 2 μl of DNA. Amplification of the second round was carried out in a 25 μl reaction mixture consisting of 12.5 μl of 2× PCRBIO Taq Mix Red (PCR Biosystems, London, UK), 400 nM of each primer, and 1 μl of the first PCR round as the template. One positive control, consisting of DNA from carnivores previously confirmed as positive for the targeted pathogens [18, 64, 68], and a negative control represented by sterile water were included in each reaction set. Amplicons were visualized on 1.5% agarose gels stained with ECO Safe Nucleic Acid Staining Solution (PacificImage Electronics, New Taipei City, Taiwan).

Products of expected size were cut from gels and purified using the Gel/PCR DNA Fragments Extraction Kit (Geneaid Biotech Ltd., New Taipei City, Taiwan). PCR products were sequenced with Sanger sequencing technology in both directions (performed at Macrogen Europe, Amsterdam, the Netherlands) using the amplification primers. Chromatograms were assembled and edited using Geneious 4.8.5 software [69], and consensus sequences were compared to homologous sequences available in the GenBank® database using the NCBI Basic Local Alignment Search Tool (BLASTn) analysis. Protein coding gene sequences were translated to corresponding amino acids, based on the protozoan mitochondrial genetic code, to guide nucleotide alignment.

To investigate the relations among Babesia spp., phylogenetic analysis of the 18S rDNA and Cytb genes was performed using MEGA X software [70] based on all unique sequences obtained in the present study and available sequences of Babesia sensu stricto clade VI, according to Schnittger et al. [2], longer than 300 bp. In the case of Cytb, B. pisicii was also included in the analysis. Two 18S rDNA sequences of H. felis and two Cytb sequences of Theileria parva were used as outgroups. In the case of both datasets, the sequences were aligned using the ClustalW algorithm, resulting in a final alignment of 47 sequences for the 18S rDNA and 25 for the Cytb gene, respectively. The phylogenetic trees were inferred by the maximum likelihood method. The best-fit substitution models, with the lowest Bayesian information criterion (BIC) scores, as calculated by the software, were used: Kimura 2-parameter, using a discrete gamma distribution (K2+G) for the 18S rDNA, and Tamura 3-parameter, using a discrete gamma distribution (T92+G) for the Cytb gene, respectively. Branch support was estimated using 1000 bootstrap replicates. The resulting tree topologies were visualized and edited in FigTree v1.4.4 and Inkscape 0.94.

Statistical analyses

Statistical analyses were performed using R software v. 4.0.5 (R Foundation for Statistical Computing, Vienna, Austria). The prevalence and its 95% confidence interval (CI), overall and differentiated by different epidemiological data, were calculated, and the existence of a statistical association between PCR positivity rates and explanatory variables (sex, age, breed, lifestyle, habitat, and ecoregion) was evaluated by Fisher’s exact test. P-values less than 0.05 were considered statistically significant.

Results

From the total number of sampled cats, 72 (19.4%, 95% CI 15.4–23.4) showed a visible band in the PCR targeting the 18S rDNA of piroplasmida. From these, 56 samples (15.1%, 95% CI 11.5–18.7) yielded an amplicon in the assay targeting the 18S rDNA of Babesia spp. The sequences represented five unique haplotypes. The most common haplotype (BHF014) was detected in 52 samples. The remaining four haplotypes were represented by one sample each, differing from the main haplotype by three single-nucleotide polymorphism (SNP) sites and one indel (1.12%; 4/356 nucleotides [nt]), in the case of the sample represented by ARF008, and one SNP site in the case of the other three haplotypes, respectively. The BLASTn analysis of the obtained haplotypes showed 98.9–100% nucleotide sequence identity with B. canis from dogs from Lithuania (GenBank accession numbers: MN078319-MN078323), Iran (MN173223), or Bosnia and Herzegovina (MK107800-MK107806). All sequences represented by unique haplotypes were deposited in GenBank (accession numbers OL342311-OL342315).

The amplification of the Cytb gene of Babesia spp. was successful in six samples, while no positivity was noticed in the assay targeting the Babesia spp. COI gene. Two haplotypes with 99.8% identity were detected in the six samples (1 SNP/477 nt). The sequences displayed a 99.6–99.8% identity to B. canis from the USA (KC207822) or B. canis reported in a dog from Poland (MK024727) and 99.4–99.6% identity to B. canis detected in European wild cats in Romania (MW938761). The two sequences were deposited in the GenBank database under the accession numbers OL355016 and OL355017.

From the 72 samples positive in the initial screening, two yielded an amplicon in the assays targeting the 1600-bp fragment of the 18S rDNA of Hepatozoon spp., resulting in an overall prevalence of 0.5% (95% CI 0.0–1.3). However, direct sequencing resulted in four short sequences (two forward and two reverse), that showed an overall identity of 99–100% to Hepatozoon sp. identified in ocelots from Brazil (KX776299, KX776303) or reptiles from Spain (MG787243), or H. felis reported in lions from India (KX01729, ON075470) or wild cats from Hungary (OM422756). The two samples were also positive for Babesia sp. The remaining 16 samples tested negative in all specific protocols. All sampled domestic cats were PCR negative for Cytauxzoon spp.

Statistical analyses showed that the Babesia spp. infection rate was statistically higher in cats from the Pannonian ecoregion than in the rest of the country, at a P-value of 0.03. No associations were found between the presence of the pathogens and other categorical variables (Table 2).

Table 2 Prevalence of B. canis and Hepatozoon spp. in association with epidemiological data

Phylogenetic analyses of both 18S rDNA (Fig. 1) and Cytb (Fig. 2) sequences confirmed the affiliation of our sequences to the B. canis clade, clustering together with other B. canis sequences from dogs, European wild cats or ticks, in a sister clade to B. vogeli, in the case of 18S rDNA, and to B. pisicii and Babesia rossi (bootstrap value: 98), in the case of Cytb.

Fig. 1
figure 1

Maximum likelihood tree based on partial 18S rDNA sequences obtained in the current study (in bold) and sequences of Babesia sensu stricto species (clade VI sensu Schnittger et al. [2]). Only bootstrap values above 75% are displayed. The scale bar indicates the number of nucleotide substitutions per site. The GenBank accession number, assigned name, host, and country of origin are indicated for each sequence, if available

Fig. 2
figure 2

Maximum likelihood tree based on Cytb sequences obtained in the current study (highlighted in bold) and sequences of Babesia sensu stricto species (clade VI sensu Schnittger et al. [2]). Only bootstrap values above 75% are displayed. The scale bar indicates the number of nucleotide substitutions per site. The GenBank accession number, assigned name, host, and country of origin are indicated for each sequence, if available

Discussion

The results of the current study confirmed for the first time that B. canis and Hepatozoon spp. are circulating in domestic cats in Romania. The 18S rDNA, a highly conserved region, is the primary PCR target used in studies addressing the diagnosis of piroplasmids [71, 72]. However, several studies have questioned its ability to differentiate between closely related species [2, 18, 64, 73, 74]. In the present study, BLAST analyses of the 18S rDNA sequences showed 99–100% identity with different sequences of B. canis, although the presence of this species was confirmed in only six samples by Cytb gene amplification and analyses. Babesia canis was previously reported in domestic cats in Europe, the data being supported exclusively by relatively short 18S rDNA fragments [14, 15]. Therefore, as previously highlighted [18], our recommendation remains to avoid using protocols targeting the 18S rDNA for piroplasmid species differentiation, and samples amplified by these protocols should be considered as Babesia sp. PCR protocols based on mitochondrial gene detection can be successfully used for species confirmation, but have shown lower sensitivity than 18S rDNA amplification protocols (100 to 1000 times lower sensitivity than the protocol targeting the 376-bp fragment of B. canis 18S rDNA) [18, 74].

Several Babesia species have been documented in domestic cats worldwide: B. felis [10], B. leo [75], B. lengau [76], and Babesia sp. cat Western Cape [75] in Africa; B. hongkongensis [77], B. canis presentii [78], B. panickeri [79], and B. vogeli [80, 81] in Asia; and B. vogeli and B. gibsoni in the Americas [82]. In Europe, epidemiological data on Babesia infection in domestic cats are limited to a few molecular studies targeting the 18S rDNA, with B. canis reported in Spain and Portugal [14, 15], B. vogeli in Portugal [15, 16], and B. microti in Italy [12, 13]. Babesia canis was also recently reported in wild cats from Romania [18].

Traditionally, the naming of Babesia spp. has been based on their assumed host specificity and morphological characters [2]. However, as already discussed by others [18, 83], the presence of B. canis DNA was detected in several other non-canid hosts, such as bats [84] and horses [85]. Furthermore, B. canis was molecularly detected in mice experimentally fed Dermacentor reticulatus-positive ticks, raising the possibility of oral transmission through vectors [83]. This hypothesis was also put forward by Hornok et al. [86] when B. canis DNA was identified in insectivorous bat faeces. Cats can ingest ticks, either with their prey (immature D. reticulatus feed on micromammals such as mice and voles [87]) or due to their grooming behaviour.

In wild cats in Romania, a recent study noted a prevalence of Babesia spp. infection of 39.2% [18]. However, in this previous study on wild cats [18], B. canis was confirmed in only one sample by mitochondrial marker assay, while in three samples, a novel species, B. pisicii, was described. The presence of this species was not confirmed in domestic cats.

The geographical distribution of Hepatozoon spp. in domestic cats is apparently wide in Europe, with reports originating mainly from Mediterranean countries, such as Spain [23, 24, 28, 37], Portugal [15, 16], Italy [29, 32, 35], Cyprus [27], Greece [36], and France [39], but also from Central Europe: Austria [33] and Switzerland [40]. In our study, the exact identity of the species involved could not be established due to the low quality of the obtained sequences. The low parasitaemia level observed in domestic cats during other studies [25, 35], as well as the predominance of subclinical manifestations in Hepatozoon spp. infection [26, 35], most likely contributed to these impediments. Cloning procedures presumably have the ability to improve the molecular results.

In recent decades, Hepatozoon infection in felids has been increasingly reported worldwide, usually with low infection rates, but ranging up to 37.9% in Cyprus [27]. The overall prevalence of Hepatozoon spp. in the present study was 0.5%, similar to that found in Spain [37] or Italy [32].

Piroplasms of the genus Cytauxzoon have gained increased interest in recent years in Europe, due to the high prevalence observed in wild felids [54,55,56,57,58,59,60,61,62,63,64,65,66,67] and occasional clinical reports [48,49,50,51, 53, 65]. Despite the diversity and common occurrence of Cytauxzoon infection in European wild cats [64], no positive domestic cat was found in this study. Similar results have been obtained in other large-scale surveys conducted on outdoor, stray, or feral cats in Italy [13, 88, 89] and Greece [90]. The reports of Cytauxzoon sp. in domestic cats from Europe either are clinical case reports [48,49,50,51, 53] or represent findings in asymptomatic cats from Mediterranean regions: Spain [28, 46], France [39], or Italy [35, 47, 52]. At the moment, no report of Cytauxzoon is available from healthy cats in other parts of Europe.

Conclusions

To the authors’ knowledge, this is the first report of Babesia and Hepatozoon spp. in domestic cats in Romania. Moreover, the study shows high infection rates with Babesia spp. in domestic cat populations, confirms the presence of B. canis by using a specific genetic marker, and highlights the importance of using mitochondrial genes as targets for PCR analyses that are aimed at piroplasmid species differentiation. Nevertheless, no Cytauxzoon spp.-positive samples were identified. Further studies are required to develop highly sensitive PCR assays targeting the Cytb or COI gene of Babesia spp., and to clarify the clinical implication of this pathogen in domestic cats.